Informatie:
Fout:
ID
27816
Beschrijving
A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B Infection; ODM derived from: https://clinicaltrials.gov/show/NCT00605384
Link
https://clinicaltrials.gov/show/NCT00605384
Trefwoorden
Versies (1)
- 30-11-17 30-11-17 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
30 november 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Chronic Hepatitis B NCT00605384
Eligibility Chronic Hepatitis B NCT00605384
- StudyEvent: Eligibility
Similar models
Eligibility Chronic Hepatitis B NCT00605384
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Hepatitis B, Chronic
Item
chronic hbv infection
boolean
C0524909 (UMLS CUI [1])
Lamivudine | Lamivudine Resistance
Item
history of lamivudine (lvd) treatment, and lamivudine resistance (lvdr), receiving lvd at screening visit
boolean
C0209738 (UMLS CUI [1])
C0209738 (UMLS CUI [2,1])
C1514892 (UMLS CUI [2,2])
C0209738 (UMLS CUI [2,1])
C1514892 (UMLS CUI [2,2])
Liver function Compensated
Item
compensated liver function
boolean
C0232741 (UMLS CUI [1,1])
C0205432 (UMLS CUI [1,2])
C0205432 (UMLS CUI [1,2])
Hepatitis B DNA Measurement
Item
hbv dna ≥ 172,000 iu/ml
boolean
C3641250 (UMLS CUI [1])
Hepatitis B e antigen positive | Hepatitis B e antigen negative
Item
hepatitis b e-antigen (hbeag)-positive or hbeag-negative
boolean
C0392390 (UMLS CUI [1])
C0948827 (UMLS CUI [2])
C0948827 (UMLS CUI [2])
Decompensated cirrhosis
Item
evidence of decompensated cirrhosis
boolean
C1619727 (UMLS CUI [1])
HIV coinfection | HCV coinfection | HDV Coinfection
Item
coinfection with human immunodeficiency virus (hiv), hepatitis c virus (hcv), or hepatitis d virus (hdv)
boolean
C4062778 (UMLS CUI [1])
C1698259 (UMLS CUI [2])
C0011220 (UMLS CUI [3,1])
C0275524 (UMLS CUI [3,2])
C1698259 (UMLS CUI [2])
C0011220 (UMLS CUI [3,1])
C0275524 (UMLS CUI [3,2])
Pancreatitis
Item
recent history of pancreatitis
boolean
C0030305 (UMLS CUI [1])
serum alpha-fetoprotein measurement
Item
serum alpha fetoprotein > 100 ng/ml
boolean
C0546833 (UMLS CUI [1])
Exception Lamivudine | Nucleoside Analogs Antiviral Agents Against Hepatitis B | Nucleotide analog Antiviral Agents Against Hepatitis B
Item
except lamivudine, any prior therapy with nucleoside or nucleotide analogue antiviral agents with activity against hepatitis b
boolean
C1705847 (UMLS CUI [1,1])
C0209738 (UMLS CUI [1,2])
C1579410 (UMLS CUI [2,1])
C0003451 (UMLS CUI [2,2])
C0521124 (UMLS CUI [2,3])
C0019163 (UMLS CUI [2,4])
C0597107 (UMLS CUI [3,1])
C0003451 (UMLS CUI [3,2])
C0521124 (UMLS CUI [3,3])
C0019163 (UMLS CUI [3,4])
C0209738 (UMLS CUI [1,2])
C1579410 (UMLS CUI [2,1])
C0003451 (UMLS CUI [2,2])
C0521124 (UMLS CUI [2,3])
C0019163 (UMLS CUI [2,4])
C0597107 (UMLS CUI [3,1])
C0003451 (UMLS CUI [3,2])
C0521124 (UMLS CUI [3,3])
C0019163 (UMLS CUI [3,4])